Shawn Olsson

CIK: 0002015796

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (25.0%)

Position reduction

Option Exercises (M)3 (37.5%)

Derivative conversions

Awards (A)3 (37.5%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

LENZ

LENZ Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

LENZ
LENZ Therapeutics, Inc.
Jan 2, 2026
Award(A)
Restricted Stock Unit
Direct
14K shares-
LENZ
LENZ Therapeutics, Inc.
Jan 2, 2026
Award(A)
Stock Option (right to buy)
Direct
84.2K shares-
LENZ
LENZ Therapeutics, Inc.
Nov 17, 2025
Sale(S)
Direct
5.8K shares at avg. $26.37$153K
LENZ
LENZ Therapeutics, Inc.
Nov 17, 2025
Exercise(M)
Direct
10K shares at avg. $2.08$21K
LENZ
LENZ Therapeutics, Inc.
Nov 17, 2025
Sale(S)
Direct
4.2K shares at avg. $25.74$108K
LENZ
LENZ Therapeutics, Inc.
Apr 9, 2025
Exercise(M)
Direct
1.4K shares at avg. $2.08$3K
LENZ
LENZ Therapeutics, Inc.
Jan 9, 2025
Award(A)
Stock Option (right to buy)
Direct
80.1K shares-
LENZ
LENZ Therapeutics, Inc.
Dec 16, 2024
Exercise(M)
Direct
3.3K shares at avg. $2.08$7K

		Type	Shares	Price		Ownership
Jan 2, 2026	LENZ LENZ Therapeutics, Inc.	Award(A) Restricted Stock Unit	14,000	-	-	Direct
Jan 2, 2026	LENZ LENZ Therapeutics, Inc.	Award(A) Stock Option (right to buy)	84,200	-	-	Direct
Nov 17, 2025	LENZ LENZ Therapeutics, Inc.	Sale(S)	5,788	$26.37	$152,612	Direct
Nov 17, 2025	LENZ LENZ Therapeutics, Inc.	Exercise(M)	10,000	$2.08	$20,800	Direct
Nov 17, 2025	LENZ LENZ Therapeutics, Inc.	Sale(S)	4,212	$25.74	$108,411	Direct
Apr 9, 2025	LENZ LENZ Therapeutics, Inc.	Exercise(M)	1,400	$2.08	$2,912	Direct
Jan 9, 2025	LENZ LENZ Therapeutics, Inc.	Award(A) Stock Option (right to buy)	80,100	-	-	Direct
Dec 16, 2024	LENZ LENZ Therapeutics, Inc.	Exercise(M)	3,333	$2.08	$6,933	Direct

1-8 of 8 transactions

About Olsson Shawn

Olsson Shawn (SEC CIK 0002015796) files insider reports with the SEC as Chief Commercial Officer of LENZ Therapeutics, Inc. (LENZ).

Signal8 holds 5 ownership filings by Olsson Shawn, all Form 4s, filed between Dec 17, 2024 and Jan 6, 2026. Those filings report 8 transactions, from Dec 16, 2024 to Jan 2, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Olsson Shawn's filings is in SOLANA BEACH, CA.

Recent filings by Olsson Shawn

Jan 2, 2026: Grants or awards of LENZ derivative securities (2 lines, Form 4, code A).
Nov 17, 2025: Open-market sale of LENZ shares (Form 4, code S).
Nov 17, 2025: Option exercise of LENZ shares (Form 4, code M).
Nov 17, 2025: Open-market sale of LENZ shares (Form 4, code S).
Apr 9, 2025: Option exercise of LENZ shares (Form 4, code M).

Other insiders filing for LENZ Therapeutics, Inc. (LENZ)

Chevallard Daniel R., Chief Financial Officer
RA CAPITAL MANAGEMENT, L.P., 10% Owner
George Jeffrey P., Director
Drapkin Kimberlee C, Director
MCCOLLUM JAMES W, Director
Thunen Shelley B, Director

How to read Form 4 transaction codes